Navigation Links
The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
Date:3/3/2008

Forward-Looking Statements

Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve known and unknown risk, uncertainties and other factors that may cause the Company's actual performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statement. Factors that impact such forward-looking statements include, among others, changes in worldwide general economic conditions, changes in interest rates, government regulations, and worldwide competition.

(Tables Follow)

Consolidated Statements of Operations (Unaudited)

The following represents condensed financial data (in thousands) except per share data:

Three-Months Three-Months Year Year

Ended Ended Ended Ended

December December December December

31, 2007 31, 2006 31, 2007 31, 2006

($) ($) ($) ($)

Net Sales 13,568 14,196 39,475 42,125

Gross profit 8,597 8,997 22,648 22,878

Sales & marketing

expenses 1,341 3,530 5,977 8,326

Administrative expenses 4,050 3,122 13,417 13,124

Research & development 1,694 1,286 6,490 3,820

Income taxes (benefit) - - - 89

Net income (loss) 1,661 1,246 (2,458) (1,748)

Diluted income (loss)

per share:

Net income (loss) $0.12 $0.09 ($0.19) ($0.14)

Diluted weighted


'/>"/>

SOURCE The Quigley Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. The Quigley Corporation Announces Sale of Its Health and Wellness Segment
2. Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call
3. Dialysis Corporation of America Announces Fiscal Year 2007 Earnings Release Date
4. Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results
5. National Atlantic Holdings Corporation to Report Fourth Quarter and Year-End 2007 Earnings on March 17, 2008
6. Linkwell Corporations Skin Disinfectant Product Chosen for 2008 Beijing Olympic Games
7. Partners Center for Connected Health and EMC Corporation Launch New Web-Based Remote Monitoring Program to Help Employees Fight Hypertension
8. China Bionanometer Industries Corporation Announces New Products for China
9. Centene Corporation Unveils Winners of the 2008 Physician Summit Award
10. Dialysis Corporation of America Announces its Newest Center Opening in South Carolina
11. Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 1Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 2Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 3Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 4Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 5Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 6Torrids Model Search Winners Celebrities Celebrate Fashion and Help Support the National Breast Cancer Foundation at the House of Dreams Event 59235 1Torrids Model Search Winners Celebrities Celebrate Fashion and Help Support the National Breast Cancer Foundation at the House of Dreams Event 59235 2MDMA Board Unanimously Opposes Medical Device Tax 5366 1MDMA Board Unanimously Opposes Medical Device Tax 5366 2